Yvonne  Tran net worth and biography

Yvonne Tran Biography and Net Worth

EVP of Schrodinger
Yvonne Tran, Executive Vice President and Chief Legal Officer, joined Schrödinger in 2010. Prior to joining Schrödinger, she served as Senior Corporate Counsel at Oracle America, Inc. and as Deputy General Counsel at DoubleClick Inc. As an in-house lawyer, she negotiated complex intellectual property and commercial transactions and provided legal support on M&A matters and intellectual property litigations. Yvonne worked at various law firms in New York immediately after law school, and her practice included intellectual property counseling and litigation. She has extensive experience in the software and technology services industries. Yvonne graduated from Yale in 1992 with a B.A. in Molecular Biophysics & Biochemistry and from the University of Virginia School of Law in 1995.

What is Yvonne Tran's net worth?

The estimated net worth of Yvonne Tran is at least $583.73 thousand as of March 5th, 2026. Ms. Tran owns 52,683 shares of Schrodinger stock worth more than $583,728 as of March 29th. This net worth approximation does not reflect any other assets that Ms. Tran may own. Learn More about Yvonne Tran's net worth.

How do I contact Yvonne Tran?

The corporate mailing address for Ms. Tran and other Schrodinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrodinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Yvonne Tran's contact information.

Has Yvonne Tran been buying or selling shares of Schrodinger?

During the last ninety days, Yvonne Tran has sold $24,810.46 in shares of Schrodinger stock. Most recently, Yvonne Tran sold 1,094 shares of the business's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $12.89, for a transaction totalling $14,101.66. Following the completion of the sale, the executive vice president now directly owns 52,683 shares of the company's stock, valued at $679,083.87. Learn More on Yvonne Tran's trading history.

Who are Schrodinger's active insiders?

Schrodinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Margaret Dugan (Insider), Ramy Farid (CEO), Jenny Herman (SVP), Rachit Jain (CFO), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), Kenneth Lorton (COO), Geoffrey Porges (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrodinger's active insiders.

Are insiders buying or selling shares of Schrodinger?

During the last twelve months, insiders at the sold shares 14 times. They sold a total of 33,458 shares worth more than $649,577.89. The most recent insider tranaction occured on March, 6th when CAO Jenny Herman sold 608 shares worth more than $7,806.72. Insiders at Schrodinger own 21.0% of the company. Learn More about insider trades at Schrodinger.

Information on this page was last updated on 3/6/2026.

Yvonne Tran Insider Trading History at Schrodinger

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2026Sell1,094$12.89$14,101.6652,683View SEC Filing Icon  
2/10/2026Sell776$13.80$10,708.8022,859View SEC Filing Icon  
2/12/2024Sell758$28.29$21,443.8211,963View SEC Filing Icon  
6/30/2023Sell12,040$50.00$602,000.0012,721View SEC Filing Icon  
5/23/2023Sell7,960$40.01$318,479.6012,721View SEC Filing Icon  
4/1/2021Sell13,377$79.58$1,064,541.6630,508View SEC Filing Icon  
2/22/2021Sell10,000$113.66$1,136,600.0026,731View SEC Filing Icon  
See Full Table

Yvonne Tran Buying and Selling Activity at Schrodinger

This chart shows Yvonne Tran's buying and selling at Schrodinger by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Schrodinger Company Overview

Schrodinger logo
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Read More

Today's Range

Now: $11.08
Low: $10.95
High: $11.54

50 Day Range

MA: $12.97
Low: $11.08
High: $17.33

2 Week Range

Now: $11.08
Low: $10.94
High: $27.63

Volume

991,801 shs

Average Volume

1,131,783 shs

Market Capitalization

$817.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57